European foulbrood (EFB) is a severe bacterial honey bee brood disease caused by the Gram-positive bacterium Melissocccus plutonius. The disease is widely distributed worldwide, and is an increasing problem in some areas. Although the causative agent of EFB was described almost a century ago, many basic aspects of its pathogenesis are still unknown. Earlier studies were hampered by insensitive and unspecific methods such as culture based techniques. Recent advances in molecular technology are making it increasingly easy to detect and characterize microbes, and nucleic acid detection technologies are quickly displacing the traditional phenotypic assays in microbiology. This paper presents selected methodologies which focus on EFB and its causative agent M. plutonius.
Introduction

Background
European foulbrood (EFB) is a bacterial brood disease caused by the Gram positive bacterium Melissococcus plutonius. EFB is listed in the OIE Terrestrial Animal Health Code (2011), but, unlike American foulbrood; it is not notifiable in all countries. The disease occurs in honey bees throughout the world, and may cause serious losses of brood and colony collapse. In many areas, the disease is endemic with occasional seasonal outbreaks, but, in a few countries, the scenario is different. In Switzerland, the incidence of EFB has increased dramatically since the late 1990s; it has become the most widespread bacterial brood disease in the UK, and Norway reported a regional outbreak of EFB during 2010 after a 30 year period of absence.
Geographically, the disease appears to vary in severity from being relatively benign in some areas but increasingly severe in others (Wilkins et al., 2007; Dahle et al., 2011; Grangier, 2011; Arai et al., 2012) . Virulence tests on individual larvae using exposure bioassays (see section 9), shows that M. plutonius strains collected in different geographic European locations vary in their ability to cause larval mortality (Charrière et al., 2011) .
Disease symptoms
The field diagnosis of EFB is based on the visual inspection of brood combs and detection of diseased larvae (see section 4). The general symptoms observed in a colony suffering from EFB are irregular capping of the brood; capped and uncapped cells being found scattered irregularly over the brood frame (known as pepper pot brood). The youngest larvae that die from the infection cover the bottom of the cell and are almost transparent, with visible trachea. Older larvae die malpositioned and flaccid in their cells; twisted around the walls or stretched out lengthways (Fig. 1 ). The colour of affected larvae changes from pearly white to pale yellow, often accompanied by a loss in segmentation. More advanced symptoms can manifest as further colour changes to brown and greyish black ( Fig. 1) , sometimes ultimately leaving a dark scale (Fig. 2 ) that is more malleable than those typically found with American foulbrood (AFB).
Secondary bacteria
Several other bacteria such as: Enterococcus faecalis; Achromobacter euridice; Paenibacillus alvei and Brevibacillus laterosporus may be associated with EFB (Forsgren, 2010) . Although the presence of P. alvei -like spores of E. faecalis has been considered presumptive evidence of European foulbrood, the role of such secondary bacterial invaders in disease development has been poorly investigated.
A. euridice is frequently isolated in mixed culture with M. plutonius and EFB symptoms in larvae may be more easily induced with inoculate containing M. plutonius in combination with A. euridice or P. alvei (Bailey, 1957) . However, a more recent study from Switzerland showed that the simultaneous or 3 days delayed inoculation of P. alvei had no influence on the virulence of M. plutonius in individual larvae (Charrière et al., 2011; see section 9.2) . This paper will focus solely on techniques for diagnosis and research of the causative agent of EFB, M. plutonius.
Diagnosis
Symptoms of EFB may easily be confused with other diseases or abnormalities in the brood, making diagnosis difficult. The diagnosis in the field can be further verified by microscopic examination of brood smear preparations (see section 6; Hornitzky and Wilson, 1989; Hornitzky and Smith, 1998) , and a field test kit (see section 7.2) for the detection of M. plutonius in larval extracts is also available (Tomkies et al., 2009) . Analysing pooled samples of bees from the to visual inspection (Roetschi et al., 2008) , although false negatives may sometimes occur (Budge et al., 2010) . Sensitive detection methods are required to ensure the absence of the bacterium from bee products and for the confirmation of the visual diagnosis made in the field or for research purposes. Pure isolates of M. plutonius may sometimes be desirable for various research purposes (see section 5).
There are selective media for the cultivation of M. plutonius (Bailey, 1957; Bailey, 1983; Bailey and Collins, 1982; Hornitzky and Wilson, 1989; Hornitzky and Karlovskis, 1989) , but to culture the bacterium can be difficult and there is some evidence that M. plutonius samples from different regions have a differential response to culturing (Allen and Ball, 1993; Arai et al., 2012) . Immunology-based tests such as enzyme linked immuno-sorbent assay (ELISA) (Pinnock and Featherstone, 1984) have been published and used for the detection and quantification of M. plutonius (see section 7.1), but DNA amplification using the polymerase chain reaction (PCR) provides lower thresholds of detection than ELISA, and has been successfully used for the detection of M. plutonius since the late 1990s (see section 8).
This paper therefore aims to present selected protocols useful for diagnosis and research on the honey bee brood disease European foulbrood.
Bio-safety recommendations
It is important to appreciate that there is no internationally accepted 
Sampling
Methods can be grouped into those looking to confirm the presence of the disease by testing an individual symptomatic larva for M. plutonius, and those that hope to confirm the presence of M. plutonius in asymptomatic material, such as in bulk samples of adult bees or disease-free colonies in proximity to disease. When considering the latter, it is important to consider the within-hive distribution of the pathogen and also how the sample size may affect the power of the subsequent test. For example, when assuming a hive population of 50,000 individuals, sampling 5 adult bees provides a 95% confidence of detecting a pathogen with a minimum prevalence of 50%, whereas sampling 60 adult bees increases the power of the testing regime to enable a more meaningful minimum pathogen detection of 5% Graaf et al., 2013; Human et al., 2013) .
Storage temperature is not crucial. All sample types can be refrigerated for several hours and stored at -20ºC for longer periods.
Brood
Upon visual inspection in the field, large pieces of symptomatic brood may be cut out and sent to the laboratory (a piece of 10 x 10 cm cuts through the metal wires of the brood frame) for further examination and confirmation of the diagnosis. Correct sampling of brood is important because even within the same brood frame, M. plutonius is mainly found in larvae with visual disease symptoms (Forsgren et al., 2005) . Alternatively, and in cases of lower severity, diseased larvae can be smeared on a microscope slide and submitted to the laboratory (see section 6). M. plutonius can survive for over three years on such slide preparations (Bailey, 1960) , and 6 years within Lateral Flow Devices (Budge, unpublished data) , and so culturing often remains a viable option many years after diagnosis.
It is possible to identify the presence of M. plutonius in the absence of disease symptoms by collecting bulk samples of 100 larvae, taken at random from across the brood nest and subjecting the samples to qPCR (Budge et al., 2010 ; see also the molecular methods paper of the BEEBOOK (Evans et al., 2013) . This method provided robust quantification of M. plutonius and is a potentially useful tool to help predict the risk of a colony either prior to disease development or in the absence of an inspection to confirm disease (Fig. 3 ).
Adults
Analysis of worker bees indicates that individuals from the brood nest contain more bacteria than bees from flight entrances; therefore, it was suggested that samples of bees are preferably collected from the brood nest (Roetschi et al., 2008) . This result has not been replicated by others, where the amount of M. plutonius in foragers equalled that found in nurse bees (Budge, unpublished data) . Pooled samples of 100 bees have been used for DNA extraction (Roetschi et al., 2008; Budge et al., 2010) ; however, adult bees show more variation in the amount of M. plutonius detected than samples of larvae (Fig. 3 ).
Honey and pollen
Brood nest honey, bulk honey and pollen have to some extent been used to confirm the presence of bacteria using culture methods (see section 5) and PCR (see section 8) in both diseased and healthy looking colonies Smith, 1998, McKee et al., 2003) .  20 g of agar 2. Add 100 ml of 1M KH 2 PO 4 (pH 6.7)
Cultivation of M. plutonius
3. Adjust the pH to 6.6 using 2.5 M KOH. 1. Mix all ingredients and make up to 1000 ml with distilled water.
2. Adjust to pH 7.2 with 5M KOH. is made up in 250 or 500 ml amounts, then autoclaved, this base can be kept for quite a long time (2-3 months or longer), but if the cysteine is added before autoclaving, the base will only keep a week at the most.
Agar plates
1. Melt the agar base in a steamer and cool to 46°C.
2. Add 625 µl of a freshly made 0.2 µm filter sterilized 10% solution of cysteine hydrochloride (does NOT keep at all) to 250 ml of the agar base, or 1.25 ml for 500 ml of base.
Make sure the agar is mixed well, but not bubbly as soluble starch settles out.
3. Pour immediately into petri-dishes.
4. Cool and dry in the lamina flow for 20 minutes.
5. Use the plates as soon as possible.
It is not advised to keep unused plates to use another day.
Anaerobic incubation
1. Seal in an anaerobic jar as soon as possible with an anaerobic indicator (Oxoid BR055B) and Oxoid AnaeroGen anaerobic generator sachet (appropriate size for anaerobic jar volume.
AnaeroGen AN025A for 2.5 l jar, AnaeroGen AN035A for 3.5 l jar).
2. Incubate for about a week at 35°C.
The anaerobic indicator should go colourless from pink after a few hours incubation. If it does not, the jar has failed to achieve anaerobic conditions. 
Medium for long-term storage
Carbol fuchsin staining
Prepare the carbol fuchsin stain by mixing the following 2 solutions.
Solution A: 0.2 g basic fuchsin and 10 ml 95% ethanol.
Solution B: 5 g phenol and 90 ml distilled water.
Procedure:
1. Select larvae and/or pupae showing signs of European foulbrood and place them on a microscope slide.
2. Using a swab or stick, pulp the larvae together and spread over the slide pushing any excess off one end, to leave a thin smear. Allow the smears to dry before processing.
3. Heat fix by flaming the slide over a burner a few times.
4. Flood with 0.2% carbol fuchsin for 30 seconds.
5. Wash off the stain and either air dry or gently blot dry before microscopic examination at 1000 times magnification.
A diagnosis of European foulbrood is made if examination revealed M. 
Gram staining
Gram-staining is a four part procedure which uses certain dyes to make a bacterial cell stand out against its background. The reagents you will need are:  Safranin (the counter stain)
1. Mount and heat fix the specimen (about 6 times through the flame).
2. Flood (cover completely) the entire slide with crystal violet.
3. Let the crystal violet stand for about 60 seconds.
4. Flood your slide with the iodine solution.
5. Let it stand for 60 seconds.
6. Rinse the slide with water for 5 seconds and immediately proceed to next step.
7. Rinse the slide with decolourizer for 20-60 seconds.
8. Rinse the slide carefully with water for about 5 seconds.
9. Apply the counter stain, safranin, by flooding the slide with the dye.
10. Let it stand for about 10-15 seconds.
11. Rinse with water for 5 seconds.
12. Dry the slide with paper or allow it to air dry.
13. View it under the microscope at 1,000 times magnification (Fig. 6 ).
Immunology-based methods
Various laboratory techniques based on the use of antibodies to visualize or distinguish between microorganisms exist. The key component in any of the vast array of methods used is the antibody.
Polyclonal antibodies against M. plutonius can be prepared by injection of washed cultures of M. plutonius into rabbits either by intravenous injections (Bailey and Gibbs, 1962) Photo by Michael Hornitzky
ELISA (Enzyme Linked Immuno Sorbent
Assay)
The enzyme-linked immunosorbent assay (ELISA) is a common serological test for particular antigens or antibodies. There are two forms of the test: i. the direct ELISA employs antibodies to detect presence of a particular antigen in a samples and; ii. the indirect ELISA is usually used to detect specific antibodies in a specimen such as blood serum. However, the indirect ELISA method can also be applied for detection of antigens as described in section 7.1.3. The ELISA method described by Pinnock and Featherstone (1984) is unable to detect bacterial levels less than 10 5 cells per ml.
Sample processing
Individual or pooled samples of bees, larvae or pupae (sampled and stored at -20ºC) can be crushed in phosphate buffered saline, PBS, pH 7.4 (for the recipe, see Table 1 of the cell culture paper of the BEEBOOK ) , the homogenate centrifuged for 10 sec at 10,000 g and the supernatant stored at -20°C or used directly in an ELISA.
Indirect ELISA
The reagents needed to perform the ELISA are:
 Bicarbonate / carbonate coating buffer, 100 mM, pH 9.6.
 Phosphate buffered saline, PBS, pH 7.4.
 Blocking solution (PBS with 1-2% BSA).
 Washing buffer (PBS with 0.05% Tween 20).
 Primary antibody (rabbit, chicken, mouse).
 Peroxidase or alkaline phosphatase-conjugated secondary antibody (anti-rabbit, anti-chicken; anti-mouse).
 Substrate for peroxidase alkaline phosphatase-conjugated secondary antibody (e.g. TMB (3,3´,5,5´-tetramethylbenzidine)).
 Stop solution (0.5 M H 2 SO 4 ).
 Microtiter plates.
 Microtiter plate reader.
Many different types of enzymes can be used for detection.
Peroxidase-conjugated secondary antibodies and TMB (3,3´,5,5´-tetramethylbenzidine) are commonly used and accessible.
1. Dilute the bee homogenates in coating buffer.
The total protein concentration should not exceed 20 µg per ml.
2. Coat the wells of a microtiter plate with 100 µl per well of the antigen dilution.
3. Cover the plate using an adhesive plastic.
4. Incubate for 2 hours at room temperature or at 4°C over night.
5. Remove the coating buffer.
6. Wash the plates two times filling the wells with washing buffer.
7. Block the remaining protein-binding sites by adding 200 µl blocking solution to the wells.
8. Incubate for 2 hours at room temperature or at 4°C over night.
9. Wash the plate two times with washing solution.
10. Add 100 µl of the M. plutonius specific antibody diluted in blocking solution.
11. The optimal dilution should be determined using a dilution assay. 
Lateral flow immunoassay (LFI)
A commercially available lateral flow device for the detection of M. plutonius using specific monoclonal antibodies is available. The kit was designed primarily for the confirmation of disease symptoms in the field, but may also be used in the laboratory (Tomkies et al., 2009 ).
The kit is produced by Vita (Europe) Ltd and the protocols available at: http://www.vita-europe.com. Using LFIs gives an instant result (meaning no time delay between disease suspicion and treatment), no expensive equipment required and is relatively cheap compared to posting the samples to the laboratory for diagnosis. However, it works only on single larvae and requires field knowledge to select the correct/infected larvae in a brood sample (see section 1.2).
PCR-based methods
Detection of infectious microorganisms has been revolutionized by the polymerase chain reaction (PCR), and has increasingly been described as the "gold standard" for detecting some microbes. Theoretically, a single target DNA molecule is sufficient for detection, making PCR one of the most sensitive biological techniques ever described. For a more generic overview on PCR-based methods and other molecular biology methodologies used in A. mellifera research see the molecular methods paper of the BEEBOOK (Evans et al., 2013) .
Processing
Samples can be homogenized with glass beads in mechanical 'bead mills', in mesh bags (e.g. Bioreba, Neogen) using a grinding pestle, a stomacher (e.g. Seward Ltd UK) or in microfuge tubes with a micropestle. The choice depends on sample size and type. Individuals can be extracted in the manufacturer´s buffer directly, but for bulk samples a primary extract may be necessary (see section 8.2.1).
DNA extraction
Cellulose-based affinity columns such as QIAGEN, or generic equivalents are most practical for obtaining clean DNA preparations.
They are reliable and yield good quality DNA. Magnetic bead-based purification also works well (e.g. Budge et al., 2010) . Since samples of adult bees contain more secondary metabolites and phenolics than larvae, including a QiaShredder in the protocol will yield purer nucleic acid (DNeasy ® Plant Mini Kit) and prevent inhibition of the PCR reaction. This is also recommended when extracting bacterial DNA from honey. The columns can be used for manual DNA extraction or in a QiaCube ® (QIAGEN) for automated extraction. There are two options when considering extraction controls for the quantification of M. plutonius in honey bee samples. First, it is possible to monitor extraction efficiency using a honey bee reference gene (e.g. 18S; Budge et al., 2010) . Alternatively extraction failures or PCR amplification inhibition can be monitored by amending the sample with a known amount of Staphylococcus aureus before extraction (Grangier, 2011) . It is also recommended to include a negative extraction control (e.g. water) to check for possible contamination during the extraction process (Bustin et al., 2009) . For further information on nucleic acid extraction see the molecular methods paper of the BEEBOOK (Evans et al., 2013) .
Adults
1. Place adult bees in filter grinding bag (Neogen™, Bioreba).
2. Add 0.5 ml grinding buffer (e.g. GITC 1 ) per bee.
3. Crush the bees.
4. Transfer 1.5 ml of the supernatant to a 2 ml Eppendorf tube.
OR; include a "crude" centrifugation step for bigger volumes.
5. Centrifuge at 2,000 g for 10 minutes.
6. Transfer 1.5 ml to an Eppendorf tube.
7. Centrifuge at 20,000 g for 2 minutes. For automated DNA extraction using a QiaCube ® (QIAGEN);
follow the purification of total DNA from plant tissue standard protocol.
11. Use the DNA templates directly in a PCR or store in -20ºC until needed.
1 GITC = for 100 ml, add 50 g guanidine thiocyanate, 50 ml nuclease free water, 5.3 ml 1M Tris-Cl (pH 7.6), 5.3 ml 0.2 M EDTA. Stir until completely solved and store at 4ºC.
Larvae / pupae
1. Place the larva / pupa in an Eppendorf tube.
2. Add 0.5 ml grinding buffer (e.g. GITC).
3. Ground with a micropestle.
4. Centrifuge for 10 min at 7,500 g. 8. Use the DNA templates directly in a PCR or store in -20ºC until needed.
Honey
1. Heat 5 ml of honey to 40ºC.
2. Mix thoroughly with an equal volume of PBS.
3. Centrifuge at 27,000 g for 20 minutes.
4. Discard the supernatant.
5. Resuspend the pellet in the manufacturer`s lysis buffer (DNeasy ® Plant Mini Kit, QIAGEN).
Follow the protocol for plant tissue (Mini Protocol).
6. Use the DNA templates directly in a PCR or store in -20ºC until needed. 
PCR
When PCR is used solely for detecting the presence or absence of a specific DNA signature, it is referred to as qualitative PCR (yes or no answer). The qualitative PCR detects only the end product whereas the real-time PCR detects the amplicon as it accumulates and determines the number of new DNA molecules formed in each reaction. The amount of the target molecule can be quantified (qPCR)
either relatively or as absolute values or numbers (for further general information see the molecular methods paper of the BEEBOOK (Evans et al., 2013) ).
Four protocols for the detection and quantification of M.
plutonius using PCR have been published to date (Table 2) . Two protocols for qualitative PCR; one for detection in diseased larvae (Govan et al., 1998 ) and a hemi-nested PCR assay (Djordjevic et al., 1998 plutonius.
Real-time PCR assays for the quantification (qPCR) of M.
plutonius (Roetschi et al., 2008; Budge et al., 2010) have been used to analyse pooled samples of brood nest workers from several colonies within an apiary as a suggested alternative to routine visual brood control (Roetschi et al., 2008) . However, more recent results suggest the amount of M. plutonius in adult bees provides a less stable estimate of the likelihood of finding disease than using larvae (Budge et al., 2011) . The qPCR method can also be used to attribute a risk of EFB infection to collected samples measured as probability of the sample showing clinical symptoms and providing a trigger for later inspection of apiaries at risk (Budge et al., 2010; Grangier, 2010) .
This may provide a definitive diagnosis of EFB, based on a combination of the presence of clinical disease and the confirmed presence of M. plutonius. However, in some territories, the costs of such preliminary screening using real-time PCR may not be economically viable (Grangier, 2011) . is conducted, and a specific 276 bp hemi-nested product is amplified from the 486 bp template.
Quantitative PCR, qPCR
Procedure (after Budge et al., 2010 ):
1. Genomic DNA is amplified in a 25 µl reaction comprising: bacteria in 0.1 ml, 647,000 bacteria per ml.
Total or microscopic count
A direct microscopic or total count is the enumeration of bacteria found within a demarcated region of a slide, a counting chamber. The slide is placed under a microscope, preferably with phase contrast.
For counting bacteria, an oil immersion lens is usually required (1000 x magnification). For the procedure description refer to the section on hemocytometer counting in the miscellaneous methods paper of the BEEBOOK (Human et al., 2013) .
Protocol for inducing EFB infection in honey bee larvae reared in vitro
A protocol for inducing EFB involves grafting an individual larva (less than 24 hours old) into a single well in a micro-titer plate (for detailed protocols see the in vitro rearing paper of the BEEBOOK (Crailsheim et al., 2013) ). Older larvae may also become infected but are less susceptible. Each larva is fed 10 µl of larval diet (Crailsheim et al., 2013) containing a defined number of M. plutonius cells (e.g. 500,000; see section 9.1.2). From 72 hours post grafting, the larvae are examined for mortality and fed uninfected feed daily, following the feeding regime recommended in Crailsheim et al. (2012) . The mortality of the larvae can be evaluated using a microscope or by eye. Dead larvae are distinguished by the lack of respiration and loss of body elasticity.
The ability of M. plutonius to produce symptoms in the absence of secondary bacteria such as P. alvei seems to differ regionally. In Australia, feeding only M. plutonius has been demonstrated not to produce the typical clinical signs of EFB, but in Europe, M. plutonius was capable of inducing significant mortality in isolation (Charrière et al., 2011) . When infecting with M. plutonius in combination with P. alvei, the larval colour changes to a greyish brown rather than a yellowish colour and the gut content of infected larvae turns watery exponential phase of the amplification curve and obtain an appropriate Cq.
5. To account for variation in extraction efficiency between samples, the result can be expressed as a ratio of the number of M. plutonius and A. mellifera cells.
Estimating the concentration of bacteria
The plate (viable) count method is an indirect measurement of bacterial cell density as it only detects live (or cultivable) bacteria whereas the microscopic (total) count includes all bacterial cells, cultivable or not (see the miscellaneous methods paper of the BEEBOOK (Human et al., 2013) ).
Plate count
The plate count method means diluting bacteria with a diluent solution (e.g. sterile saline) until the bacteria are dilute enough to count accurately when spread on a plate. The assumption is that each viable bacterial cell will develop into a single colony. Bacterial cell numbers need to be reduced by dilution, because more than 200 colonies on a standard 9 cm plate are likely to produce colonies too close to each other to be distinguished as distinct colony-forming units (CFUs).
The materials needed to perform a plate count are: 
Measuring susceptibility / resistance to antibiotics of
Melissococcus plutonius
Due to the fastidious culture requirements and slow growing nature of M. plutonius, measuring antibiotic susceptibility of this organism using traditional techniques such as a disc diffusion assay, which is a test that uses antibiotic -impregnated discs to determine whether particular bacteria are susceptible to specific antibiotics, is not possible.
Oxytetracycline hydrochloride (OTC) is the antibiotic of choice for the treatment of EFB. However, only two reports of the sensitivity of M. plutonius to this antibiotic have been published (Waite et al., 2003; Hornitzky and Smith, 1999) and both these studies indicated that all strains tested were sensitive to OTC. In both studies an agar plate method was used. This involves incorporating antibiotic at decreasing concentrations into culture plates (see section 5) of EFB culture medium, to determine the lowest concentration at which growth would occur. This methodology would be suitable for testing the susceptibility of M. plutonius to other antibiotics.
Conclusions
The pathogenic mechanisms of EFB are poorly understood, and the factors and timescales leading to overt symptomatology remain enigmatic. Molecular tools will open new possibilities for the identification of putative virulence factors in both the bacterium as well as the host in order to unravel some of the pathogenic mechanisms. To date, there are no published methods for genotyping and molecular differentiation of M. plutonius strains, but the nucleotide sequence of the bacterial genome was recently deposited in the DNA Database of Japan under accession no. AP012200 and AP012201 (Okomura et al., 2011) , and it is likely that new molecular methods such as genotyping will be developed in the near future.
Moreover, research fields and methods already in use for research on P. larvae such as selection of reference genes, quantifying and knocking down gene expression (see designated parts in the American foulbrood and molecular protocols papers of the BEEBOOK (deGraaf 12 Forsgren et al. et al., 2013; Evans et al., 2013) ) could be adapted to M. plutonius and EFB research. Moreover, new technologies may also be useful tools to study interactions between secondary bacteria and the causative agent and to fully understand their role in symptomatology.
Molecular diagnostic methods such as PCR are also widely employed for EFB diagnosis. The PCR method is user-friendly and theoretically, a single target DNA molecule is sufficient for detection, making it one of the most sensitive biological techniques ever described. Considering this, we might ask whether a positive PCR result is always biologically relevant. Low levels of M. plutonius can be found in apiaries where no symptoms of disease are present and the PCR will also detect non-viable bacterial cells. However, it is clear that M. plutonius is still below the level of detection in honey bee colonies located in some geographical areas (Budge et al., 2010) . Future work should help understand whether this observation is due to the genetics of the honey bees from these areas, unfavourable meteorological conditions, lower apiary density, gut microbiota unfavourable to disease development, or simply down to an absence of movement of the causative organism.
Infectivity tests causing disease at the colony level using both cultured M. plutonius and extracts from diseased larvae were carried out during the 1930s (Tarr, 1936) and the 1960s (Bailey, 1960; Bailey, 1963; Bailey and Locher, 1968) , but not much has been published since. This is an area of research where new information can be obtained by a combination of colony level infection experiments and modern diagnostic methods. Such advances would benefit from cross country collaborations, where advanced diagnostics from one country may complement field trials in another country where there may be less stringent rules governing EFB control.
